Doxazosin
- 1 May 1988
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 35 (5), 525-541
- https://doi.org/10.2165/00003495-198835050-00003
Abstract
Synopsis Doxazosin is a long-acting selective α1-adrenoceptor antagonist structurally related to prazosin. Like prazosin, doxazosin exerts its antihypertensive effect by reducing total peripheral...Keywords
This publication has 57 references indexed in Scilit:
- A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertensionThe American Journal of Cardiology, 1987
- The Effects of Antihypertensive Drugs on Serum Lipids and LipoproteinsDrugs, 1986
- The antihypertensive effects of doxazosin: a clinical overview.British Journal of Clinical Pharmacology, 1986
- A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- The metabolism and kinetics of doxazosin in man, mouse, rat and dog.British Journal of Clinical Pharmacology, 1986
- The Effect of Oral Prazosin on Blood Pressure and Plasma Concentrations of Renin and Angiotensin II in ManClinical Science, 1981
- Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities.1980
- The Metabolic Fate of PrazosinXenobiotica, 1977